Your browser doesn't support javascript.
loading
MiR-367 regulates cell proliferation and metastasis by targeting metastasis-associated protein 3 (MTA3) in clear-cell renal cell carcinoma.
Ding, Dexin; Zhang, Yue; Wen, Lin; Fu, Jiangbo; Bai, Xue; Fan, Yuhua; Lin, Yuan; Dai, Hongshuang; Li, Qiang; Zhang, Yong; An, Ruihua.
Afiliação
  • Ding D; Department of Urology, The First Affiliated Hospital of The Harbin Medical University, Harbin 150001, China.
  • Zhang Y; Department of Urology, The Affiliated Tumor Hospital of The Harbin Medical University, Harbin 150001, China.
  • Wen L; Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
  • Fu J; Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
  • Bai X; Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
  • Fan Y; Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
  • Lin Y; Department of Biotechnology and Pharmaceutics, College of Pharmacy, Harbin Medical University-Daqing, Daqing 163319, China.
  • Dai H; Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
  • Li Q; Department of Urology, The Affiliated Tumor Hospital of The Harbin Medical University, Harbin 150001, China.
  • Zhang Y; Department of Urology, The Affiliated Tumor Hospital of The Harbin Medical University, Harbin 150001, China.
  • An R; Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
Oncotarget ; 8(38): 63084-63095, 2017 Sep 08.
Article em En | MEDLINE | ID: mdl-28968973
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China